Skip to main content
logo
Ashland Inc. (ASH)
NYSE: ASH · Real-Time Price · USD
59.91
+0.46 (0.77%)
Jan 8, 2026, 4:00 PM EST - Market closed

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222013 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2013 - 2021
United States Revenue
464.00M
Log In
Log In
Log In
Upgrade
International Revenue
1.36B
Log In
Log In
Log In
Upgrade
Revenue (Total)
1.82B
Log In
Log In
Log In
Upgrade

Revenue

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222013 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2013 - 2021
Life Sciences Revenue
641.00M
Log In
Log In
Log In
Upgrade
Personal Care Revenue
577.00M
Log In
Log In
Log In
Upgrade
Specialty Additives Revenue
511.00M
Log In
Log In
Log In
Upgrade
Intermediates Revenue
137.00M
Log In
Log In
Log In
Upgrade
Eliminations from Revenue
-42.00M
Log In
Log In
Log In
Upgrade
Revenue (Other)
-
Log In
Log In
Log In
Upgrade
Revenue (Total)
1.82B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222013 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2013 - 2021
Life Sciences Operating Income
-262.00M
Log In
Log In
Log In
Upgrade
Personal Care Operating Income
90.00M
Log In
Log In
Log In
Upgrade
Specialty Additives Operating Income
-338.00M
Log In
Log In
Log In
Upgrade
Intermediates Operating Income
8.00M
Log In
Log In
Log In
Upgrade
Unallocated and Other Operating Income
-273.00M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-20.00M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-795.00M
Log In
Log In
Log In
Upgrade

EBITDA

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222013 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2013 - 2021
Life Sciences EBITDA
-187.00M
Log In
Log In
Log In
Upgrade
Personal Care EBITDA
155.00M
Log In
Log In
Log In
Upgrade
Specialty Additives EBITDA
-254.00M
Log In
Log In
Log In
Upgrade
Intermediates EBITDA
21.00M
Log In
Log In
Log In
Upgrade
Unallocated and Other EBITDA
-273.00M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-795.00M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222013 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2013 - 2021
Change in Sales Due to Volume
-98.00M
Log In
Log In
Log In
Upgrade
Change in Sales Due to Product Pricing/Mix
-46.00M
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.